FibroGen, Inc. (FGEN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:49PM EDT. Market open.
| Previous close | 1.0700 |
| Open | 1.0600 |
| Bid | 0.9764 x 400 |
| Ask | 0.9960 x 100 |
| Day's range | 0.9327 - 1.0976 |
| 52-week range | 0.3330 - 19.4700 |
| Volume | |
| Avg. volume | 2,815,311 |
| Market cap | 97.922M |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
- Zacks
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
- Zacks
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.
© 2024 Yahoo. All rights reserved.